biopharmaceutical company
Issues related to pharmaceutical IP and supply chain. Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues. Implementation of Tax Cuts and Jobs Act (P.L.115-97). H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; issues related to international taxation. Issues related to R&D tax credit; H.R.3938, Build It in America Act. FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, H.R.4368/S.2131; all bio-pharmaceutical related provisions; H.R.3746, Fiscal Responsibility Act of 2023 (P.L.118-5) implementation; H.R.2811, Limit, Save, Grow Act of 2023. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy; Medicaid Proposed Rebate Rule. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price cap, and international pharmaceutical supply chain; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; H.R.3285, Fairness for Patient Medications Act; S.1339, Pharmacy Benefit Manager Reform Act; H.R.5378, Lower Costs, More Transparency Act; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM Accountability Act; H.R.6283, DRUG Act.
TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code BUD - Budget/Appropriations MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI CHERYL LYNN JAEGER BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT HUNTER MOORHEAD MATHEW LAPINSKI